Date | Time | Source | Announcement |
---|---|---|---|
22 Dec 2006 | 11:40 AM | Total Voting Rights | |
11 Dec 2006 | 07:00 AM | Intended Grant of Patent | |
04 Dec 2006 | 07:00 AM | Morphogenesis Inc | |
03 Oct 2006 | 07:00 AM | Additional Listing | |
02 Oct 2006 | 02:33 PM | Result of EGM | |
29 Sep 2006 | 01:03 PM | Confirmation of Share Capital | |
26 Sep 2006 | 04:46 PM | Interim Results | |
11 Sep 2006 | 07:00 AM | Propsd Aqstn & Notice of EGM | |
04 Aug 2006 | 11:06 AM | Convertible Loan Note Offer | |
18 Jul 2006 | 03:47 PM | Convertible Loan Note Offer | |
29 Jun 2006 | 12:20 PM | Final Results | |
08 Jun 2006 | 08:25 AM | Change of registered office | |
12 May 2006 | 02:54 PM | Change of Adviser | |
12 May 2006 | 02:49 PM | Directorate Change | |
03 Apr 2006 | 09:44 AM | Statement re Suspension | |
22 Mar 2006 | 06:15 PM | Change of Registered Office | |
22 Mar 2006 | 06:15 PM | Change of Registered Office | |
10 Mar 2006 | 03:45 PM | Result of EGM | |
11 Jan 2006 | 01:09 PM | Result of EGM | |
27 Sep 2005 | 01:09 PM | Interim Results | |
23 Jun 2005 | 03:42 PM | Final Results | |
08 Oct 2004 | 10:39 AM | Directorate Change | |
29 Sep 2004 | 07:01 AM | Interim Results | |
27 Sep 2004 | 02:30 PM | Result of AGM | |
28 Jun 2004 | 04:41 PM | Final Results | |
10 Mar 2004 | 10:13 AM | Holding(s) in Company | |
05 Mar 2004 | 04:06 PM | Market Maker Holding | |
03 Mar 2004 | 02:36 PM | Result of EGM | |
02 Mar 2004 | 12:02 PM | Offer Update | |
25 Feb 2004 | 01:39 PM | Market Maker Holding | |
20 Feb 2004 | 03:17 PM | Market Maker Holding | |
18 Feb 2004 | 11:52 AM | Market Maker Holding | |
09 Feb 2004 | 10:45 AM | Market Maker Holding | |
09 Feb 2004 | 07:00 AM | Issue of Equity | |
05 Feb 2004 | 12:26 PM | Holding(s) in Company | |
04 Feb 2004 | 05:36 PM | Market Maker Holding | |
03 Feb 2004 | 02:40 PM | Market Maker Holding | |
29 Jan 2004 | 11:47 AM | Holding(s) in Company | |
28 Jan 2004 | 04:51 PM | Holding(s) in Company-Replcmt | |
28 Jan 2004 | 03:30 PM | Notification Replacement | |
28 Jan 2004 | 02:23 PM | Notification of Shareholding | |
28 Jan 2004 | 11:55 AM | Holding(s) in Company | |
27 Jan 2004 | 04:45 PM | Market Maker Holding | |
27 Jan 2004 | 04:36 PM | Market Maker Holding | |
18 Dec 2003 | 10:29 AM | Holding(s) in Company | |
15 Dec 2003 | 12:39 PM | Holding(s) in Company | |
05 Dec 2003 | 12:46 PM | Holding(s) in Company | |
05 Dec 2003 | 12:44 PM | Holding(s) in Company | |
05 Dec 2003 | 09:00 AM | Further re Offer | |
04 Dec 2003 | 05:20 PM | Further re Placing |
ValiRx PLC: A Biotech Innovator on the London Stock Exchange (LSE)
ValiRx PLC, known by its ticker symbol VAL, is a trailblazer in the biotechnology sector. Its performance on the London Stock Exchange (LSE) has been remarkable, with the ValiRx share price reflecting the company's consistent growth and success.
As a member of the LSE, ValiRx PLC aligns with the London Stock Exchange Group's (LSEG) mission of supporting innovative and growing businesses. The LSEG recognises ValiRx PLC as a significant player, contributing to the robust and diverse ecosystem of the LSE.
The ValiRx share price on the LSE not only underscores its financial stability but also its strategic vision in the biotechnology industry. ValiRx PLC's journey on the LSE is a testament to its robust business model and its ability to create value for its stakeholders.
In conclusion, ValiRx PLC's association with the LSE and LSEG symbolises its commitment to growth, innovation, and value creation. As ValiRx PLC continues to thrive on the LSE, it sets the bar high for the biotechnology industry, contributing to the dynamic and diverse ecosystem of the LSEG. With its focus on cancer therapeutics, ValiRx is a key player in the healthcare sector, making strides in medical research and development.